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Summary
Recent studies have suggested that neutrophils can exert anti-inflamma-
tory effects. To determine the role of neutrophils in the acute response to
lipopolysaccharide (LPS), a component of the Gram-negative bacterial cell
wall, we challenged neutrophil-depleted and control mice with LPS and
analyzed the plasma concentrations of biomarkers indicative of the cyto-
kine and chemokine network, activation of coagulation and the vascular
endothelium, and cellular injury. We here show that neutrophils serve an
anti-inflammatory role upon LPS administration, as reflected by sustained
elevations of multiple cytokines and chemokines, and enhanced release of
nucleosomes in mice depleted of neutrophils, compared with control
mice.
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Introduction
Neutrophils are traditionally considered to be important
players in acute inflammation with a key function in the
elimination of extracellular pathogens.1 Recent investiga-
tions have indicated that the role of neutrophils in
immunity stretches beyond a limited set of pro-inflam-
matory actions in the innate immune response.2 Neu-
trophils have been implicated in chronic inflammatory
conditions and the regulation of adaptive immune
responses, and a subset of neutrophils may even exert
anti-inflammatory effects.1,2 In addition, neutrophils may
cause a misbalance in hemostasis through activation of
coagulation and concurrent inactivation of natural antico-
agulants.3
Intravenous administration of lipopolysaccharide (LPS),
a component of the outer membrane of Gram-negative
bacteria, has been used as a model of acute systemic
inflammation in humans and rodents, and is accompa-
nied by a strong increase in neutrophil counts in periph-
eral blood.4 Intravenous LPS injection in humans was
associated with the appearance of a neutrophil subset in
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the circulation that was capable of suppressing T-cell pro-
liferation and less able to adhere to endothelial cells.5,6
Significant numbers of these ‘anti-inflammatory’ neu-
trophils were detected several hours after LPS administra-
tion and these anti-inflammatory neutrophils were also
found in patients with a severe injury. Depletion of neu-
trophils in mice before LPS injection resulted in higher
plasma levels of interleukin-1b (IL-1b) when compared
with animals not depleted of neutrophils.7 The aim of the
present study was to determine the role of these anti-
inflammatory neutrophils in the systemic inflammatory,
vascular and procoagulant responses to LPS.
Material and methods
Female C57BL/6 mice were purchased from Charles
River Inc. (Maastricht, the Netherlands). Mice were
housed under specific pathogen-free conditions receiving
food and water ad libitum. Experiments were carried out
in accordance with the Dutch Experiments on Animals
Acts and approved by the Animal Care and Use Com-
mittee of the University of Amsterdam (permit number
DIX102291). Mice were studied at 12 weeks of age.
Endotoxemia was induced by intraperitoneal injection of
LPS (from Escherichia coli 055:B5; Sigma-Aldrich, St
Louis, MO; 10 mg/kg in 200 ll 09% NaCl). Mice were
depleted of neutrophils by intraperitoneal injection with
anti-mouse-GR1 (clone RB6.8C5; rat IgG IgG2b, j;
100 lg) 24 hr before LPS administration.8 Control mice
were given the equivalent amount of isotype control
antibody anti-phytochrome (clone AFRC Mac 5.1; rat
IgG IgG2b, j). Ethylenediaminetetraacetic acid anticoag-
ulated plasma was obtained before, and 4 and 24 hr
after LPS injection (n = 8 mice per group at each time-
point). White blood cell counts were determined in a
hemocytometer (Beckman Coulter, Fullerton, CA), and
differential cell counts were performed on cytospin
preparations stained with Giemsa stain (Diff-Quick;
Dade Behring, D€udingen, Switzerland).
Tumor necrosis factor (TNF), IL-10 and interferon-c
(IFN-c) were determined using a commercially available
cytometric beads array multiplex assay (BD Biosciences,
Breda, the Netherlands). IL-6, CXCL1, CXCL2, soluble
vascular cell adhesion molecule 1 (VCAM-1), soluble
E-selectin (all R&D Systems, Abingdon, UK), thrombin–
antithrombin complexes (TATc; Affinity Biologicals INC,
Ancaster, Canada) and nucleosomes9 were determined by
enzyme-linked immunosorbent assay. Plasma creatinine
and aspartate aminotransferase (AST) were measured
using a c702 Roche Diagnostics (Roche Diagnostics BV,
Almere, the Netherlands). Groups were compared by
Kruskal–Wallis test followed by Mann–Whitney U test
where appropriate. P < 005 was considered statistically
significant.
Results and discussion
Lipopolysaccharide injection induced a brisk rise in neu-
trophil counts in peripheral blood in mice treated with
the control antibody (Fig. 1). Mice treated with anti-GR1
antibody showed a persistent neutropenia. Cytokine and
chemokine responses were more sustained in neutrophil-
depleted mice; all cytokines (TNF, IL-6, IL-10, IFN-c)
and chemokines (CXCL1, CXCL2) measured were signifi-
cantly higher in mice with neutropenia 24 hr after injec-
tion of LPS (Fig. 1).
To obtain insight into the role of neutrophils in the
procoagulant and endothelial cell response to LPS we
measured the plasma levels of TATc, soluble VCAM-1
and soluble E-selectin (Fig. 2). The plasma concentration
of TATc is a measure of the generation of thrombin and
its subsequent binding of its natural inhibitor antithrom-
bin, thereby reflecting activation of the coagulation sys-
tem. Baseline TATc concentrations were lower in
neutrophil-depleted mice when compared with control
mice; however, the LPS induced increase in plasma TATc
levels did not differ between groups. Likewise, neutrophil
depletion did not modify the LPS-induced increase in
plasma soluble VCAM-1 levels, although at 24 hr post-
LPS soluble VCAM-1 concentrations tended to be lower
in neutrophil-depleted mice. Remarkably, neutrophil
depletion strongly reduced plasma soluble E-selectin con-
centrations; this effect was already detectable before LPS
injection and the LPS-induced rise in soluble E-selectin
levels was virtually absent in neutrophil-depleted mice.
Nucleosomes, which are segments of DNA wound
around histone protein cores, can be released from dead
cells by the activity of endonucleases and factor VII-acti-
vating protease.10 Nucleosomes detected in the circulation
have been used as a marker of inflammation.11 Nucleo-
somes were not detectable in plasma before LPS injection
(Fig. 2). The LPS induced an increase in plasma nucleo-
some concentrations in control mice, but notably the
increase in neutrophil-depleted mice was much higher.
Plasma markers of organ injury did not show differences
between neutrophil-depleted and control mice: creatinine
(renal function) and alanine aminotransferase (liver
injury) did not increase upon LPS administration in
either group (data not shown), whereas AST (indicative
of hepatocellular injury) similarly increased in both
groups after the induction of endotoxemia (Fig. 2), show-
ing the specificity of the strong increase in plasma nucle-
osome concentration in anti-GR1-treated mice. Notably,
the LPS-induced vascular and injurious responses had not
yet declined at 24 hr; but our study does not provide
insight into possible effects of neutrophil depletion
beyond 24 hr after LPS administration.
Neutrophils are at the front line of the innate
immune system and essential elements in host defense,
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especially against extracellular pathogens.1,2 Excessive
activity of neutrophils may cause tissue injury in non-
infectious conditions and severe infection, exemplifying
the strong pro-inflammatory nature of these cells. Recent
evidence has indicated, however, that neutrophils can
also exert immune modulating and anti-inflammatory
effects.1,2 We have studied the role of neutrophils in the
systemic host reaction elicited by LPS by comparing
cytokine, procoagulant, vascular and damage responses
in mice with or without depletion of neutrophils. Our
main finding was that neutrophil depletion was
associated with exaggerated responses to LPS, suggesting
anti-inflammatory activity of neutrophils under these
conditions.
Neutrophil depletion resulted in an enhanced cytokine
and chemokine response to intravenous LPS, which
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Figure 1. Neutrophil depletion is associated with sustained elevated cytokine and chemokine levels after intraperitoneal lipopolysaccharide (LPS)
injection. Neutrophil counts (a), cytokines [tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-10 and interferon-c (IFN-c)] (b–e) and
chemokines (CXCL1 and CXCL2) (f, g) plasma levels, 0, 4 and 24 hr after intraperitoneal LPS injection in mice treated with a control or a neu-
trophil-depleting antibody. Data are mean  SE of eight mice per group. *P < 005, **P < 001 and ***P < 0001 versus mice receiving a con-
trol antibody at the same time-point.
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Figure 2. Influence of neutrophil depletion on coagulation activation, endothelial cell activation and cell injury after lipopolysaccharide (LPS)
injection. Thrombin–antithrombin complexes (TATc) (a), soluble vascular cell adhesion molecule 1 (sVCAM-1) (b) and sE-selectin (c), nucleo-
somes (d) and aspartate aminotransferase (AST) (e) plasma levels 0, 4 and 24 hr after intraperitoneal LPS injection in mice treated with control
and a neutrophil-depleting antibody. Data are mean  SE of eight mice per group. *P < 005, **P < 001 and ****P < 00001 versus mice
receiving a control antibody at the same time-point.
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involved both pro-inflammatory mediators and the anti-
inflammatory cytokine IL-10. In accordance, LPS-induced
TNF and IL-1b production by human peripheral blood
mononuclear cells was lowered in the presence of neu-
trophils.7 This inhibitory effect of neutrophils was par-
tially reversed by the addition of a1-antitrypsin,
suggesting the involvement of a protease.7 Indeed, elastase
was shown to degrade TNF and IL-1b; however, these
data are unlikely to explain our present results, consider-
ing that elastase cannot degrade IL-10,7 whereas IL-10
levels were consistently higher in neutrophil-depleted
mice.
Neutrophils can also influence activation of the coagu-
lation system by producing neutrophil extracellular traps,
which can promote tissue-factor-mediated coagulation,
and through degranulation with release of elastase,
which can inactivate natural anticoagulants such as tis-
sue factor pathway inhibitor and thrombomodulin.3
These procoagulant effects mediated by neutrophils
might explain at least in part the lower plasma TATc
levels in neutrophil-depleted mice before LPS injection.
The current finding that neutrophil depletion did not
modify the LPS-induced rise in plasma TATc levels sug-
gests that neutrophils do not contribute to the initiation
of coagulation during endotoxemia. Although these data
do not exclude a role for neutrophils in microvascular
thrombosis during infection and sepsis, in our model
they do not play a major role. Moreover, our results do
not exclude a role for neutrophils extracellular traps
(NETs) in LPS-induced systemic inflammation.
During inflammation neutrophils adhere to the vascu-
lar endothelium, which is associated with pro-inflamma-
tory changes in both neutrophils and endothelial cells.1
Neutrophil depletion strongly reduced soluble E-selectin
levels, while not affecting the concentrations of soluble
VCAM-1. Both proteins are shed by endothelial cells
and their plasma concentrations have been used as
markers of endothelial cell activation.12 Although the
release of soluble VCAM-1 from endothelial cells can be
induced by several ADAM (a disintegrin and metallo-
protease) metallopeptidases (ADAM8, ADAM9 and
ADAM17), the protease(s) responsible for the shedding
of E-selectin remain to be discovered.13,14 Besides
ADAMs, members of two additional protease families
are important for proteolytic cleavage of cell surface
transmembrane proteins with release of a soluble extra-
cellular domain fragment: metalloproteinases and soluble
neutrophil-derived serine proteinases.13 It is tempting to
speculate that the release of soluble E-selectin was
reduced in neutrophil-depleted mice because of the lack
of a neutrophil-derived protease.
Nucleosomes are released from dying and injured
cells into the extracellular environment. The plasma
concentrations of nucleosomes are elevated in a variety
of diseases, including cancers, stroke, trauma and
sepsis15 We here show that LPS injection induces a rise
in the plasma levels of nucleosomes. This increase was
greater in neutrophil-depleted mice, suggesting that neu-
trophils limit cell death during endotoxemia and that
neutrophils are not a predominant source of nucleo-
somes during LPS-induced injury. Unaltered plasma
levels of creatinine, and the similarly modestly elevated
plasma levels of AST, in both neutrophil-depleted and
control mice suggest that the differential release of
nucleosomes in both groups does not originate from
kidneys or hepatocytes.
Neutrophils present a large phenotypic heterogeneity
and functional diversity, which partially relate to their
location (blood or tissues). Our study does not provide
conclusive information on which neutrophil subset drives
the anti-inflammatory effects exposed here by neutrophil
depletion. In addition, our study was limited to markers
of systemic inflammatory, vascular and procoagulant
responses and did not investigate the effect of neutrophil
depletion on mortality.
The data presented here suggest that neutrophilic
leukocytosis induced by intravenous LPS at least in part
serves an anti-inflammatory role, as reflected by sustained
elevations in the plasma concentrations of multiple
cytokines and chemokines, and enhanced release of nucle-
osomes in the circulation during endotoxemia in mice
depleted of neutrophils compared with non-depleted
control mice.
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